Cannabis and Dissociation
An ordinary evening. Nothing dramatic has happened. The day has been full of the usual friction — small demands, minor irritations, the continuous low-level effort of being present to other people and their needs and moods. By evening the person is tired in a way that rest doesn’t quite reach. They sit down. The silence, which should be relieving, is instead loud with their own thoughts. There is something unresolved from earlier. There is something anticipated tomorrow. The mind keeps moving, keeps returning, keeps catching on things that don’t merit the attention they are getting but won’t let go.
Then they smoke cannabis.
What follows is not simply a quieting of the noise. Something more interesting happens. The thoughts that were pressing become loose. They drift, they connect in unexpected directions, they arrive at combinations that feel almost playful — the ordinary critical sequencing of the mind giving way to something more associative, less supervised. Music that was background is suddenly present in a different way, each layer separately audible, the texture of it something to be inside rather than merely near. Food tastes different. Touch is more immediate. The body, which had been simply a container for the day’s accumulated tension, now has a surface, a presence. The room itself feels more contained, more their own, sealed off from the ordinary pressures that were pressing through it an hour ago. There is a quality of enclosure. Of having arrived somewhere. A private world with its own atmosphere, its own unhurried relation to time, its own rules — and crucially, its own distance from all the things that were too close before.
Cannabis is also often first encountered socially, in a shared altered state with its own distinctive qualities of ease and intimacy. When a group of people are in the cannabis state together, the usual social frictions — status anxiety, self-consciousness, the effort of managing how one appears — are reduced, and something that feels more relaxed and more genuinely present can emerge. With chronic use, however, this social dimension tends to migrate. What began as a shared experience becomes a private one. The evening with friends becomes the evening alone. The drug has moved from something that changed the quality of being with others to something that manages the difficulty of being with oneself. That migration is itself a clinical signal — the experience has narrowed from social to solitary, from occasional to continuous, from chosen to required.
What the cannabis state is providing, in the most precise terms, is a modification of contact. The ordinary traffic between inner and outer life — the press of one’s own thoughts, the demands of other people, the friction of the day not yet digested — has been altered. Things that were too immediate are now at a bearable distance. The membrane between self and world, which had been too permeable, has been thickened. It is that thickening — and the specific qualities of the state it creates — that makes cannabis so specifically and stubbornly compelling for certain people.
To understand why cannabis produces this specific experience, it helps to understand what it is doing in the brain. The endocannabinoid system is one of the most widely distributed neuromodulatory systems in the body. Its receptors — CB1 receptors primarily — are found throughout the brain and nervous system: in the prefrontal cortex, which governs executive function, judgment, and self-monitoring; in the hippocampus, which manages memory and the sequencing of thought; in the amygdala, which processes threat and emotional salience; in the basal ganglia, which regulate reward and habit; and in sensory processing areas throughout. This distribution is not incidental. The endocannabinoid system normally acts as a broad regulator, modulating the activity of many other neurotransmitter systems simultaneously. It plays a central role in mood, stress response, appetite, sleep, pain perception, and the way sensory information is processed and weighted.
THC, the primary psychoactive compound in cannabis, binds to CB1 receptors as a partial agonist — it mimics the brain’s own endocannabinoids but binds more persistently and at much higher effective concentrations. The result of this widespread CB1 activation is a simultaneous modulation of many systems at once: prefrontal activity shifts, reducing self-monitoring and the internal critical voice; hippocampal activity changes, loosening the ordinary sequential logic of thought and allowing more associative, non-linear mental movement; amygdala activity is altered, reducing the urgency of threat signals; and sensory processing is affected throughout, giving ordinary sensory input — sound, touch, taste — a heightened salience and immediacy. These effects together produce exactly the state described in the opening: a mind less engaged in self-criticism and more freely associating, a sensory world more vivid and present, and an emotional environment that is less pressured and more enclosed. The neurobiology maps precisely onto the experience of modified contact: what CB1 activation does across these systems is, in aggregate, alter the intensity and character of the ordinary traffic between self and world.
This helps explain why cannabis attracts a particular kind of person and a particular kind of attachment. The person whose ordinary mental life is relentlessly self-monitoring finds in cannabis the first reliable relief from that monitoring. The person whose sensory world has been crowded out by anxiety, preoccupation, and the effort of constant self-management finds that cannabis returns them to their own senses. And the person whose experience of ordinary life feels penetrating and unprotected finds in the cannabis state a quality of enclosure — a felt boundary between themselves and the world’s demands — that they have not been able to produce in any other way. The drug is unusually well suited to this particular predicament, and that fit is part of why the attachment can become so thorough.
The framework that makes sense of all this is the question of contact. Some people find the ordinary traffic between inner and outer life chronically overwhelming — not because their inner world alone is unmanageable, and not because the external world alone is too demanding, but because the membrane between self and world is too permeable. Things get in too easily. Their own states press too hard. Other people’s states press too hard. The boundary that normally regulates how much reaches you, from either direction, doesn’t hold well enough. The result is a kind of chronic overexposure — to experience generally, regardless of where it originates. Cannabis works, for this person, by thickening that membrane. It makes everything less immediate, less penetrating — inner and outer both. The person isn’t primarily fleeing themselves or fleeing the world. They are reducing the intensity of contact as such. And the specific qualities of the state they enter in doing so — the sensory richness, the mental freedom, the protective enclosure — are what make this particular thickening of the membrane so much more compelling than the alternatives.
But the relationship between cannabis and anxiety is more complicated than simple relief, and this complexity is clinically important. Cannabis acutely reduces anxiety. Over time, however, something changes. The endocannabinoid system, chronically stimulated by exogenous THC, responds as it responds to any repeated pharmacological pressure: CB1 receptors begin to downregulate and internalize, becoming fewer and less sensitive. The system’s natural function — which includes an important role in modulating anxiety as part of its baseline regulatory work — is progressively compromised. The person’s baseline anxiety, away from cannabis, rises.
What makes this so clinically difficult is that the process is essentially invisible from inside. The person does not experience themselves as someone whose drug use is generating anxiety. They experience themselves as an anxious person for whom cannabis provides necessary relief. The evidence available to them — that they feel worse when they don’t use, and better when they do — consistently confirms the picture they already hold. Nothing in their immediate experience points toward the drug as the source of the problem rather than its solution. The cycle is self-reinforcing precisely because it is self-concealing: each episode of anxiety away from cannabis feels like evidence of an underlying condition, not like the withdrawal state of a compromised regulatory system. By the time the person is using heavily enough that the distortion is significant, they have usually been inside this picture long enough that it feels simply like the truth of who they are.
The experience also changes with chronic use, though this too tends not to be recognized clearly from inside. Early cannabis often feels genuinely revelatory — the sensory richness is striking, the mental freedom feels like discovery, the protected world has a quality of genuine novelty. Chronic cannabis is usually much flatter. The heightened sensory experience has become ordinary or absent. The associative mental freedom has become a familiar, somewhat monotonous loop. The protective enclosure is no longer an alternative world entered with some sense of arrival; it is simply where the person now lives, by default, most of the time. Yet the dependence deepens even as the experience flattens, because the alternative — unmediated ordinary experience without the membrane — now feels worse than it did before they began. The CB1 downregulation means the endocannabinoid system’s natural regulatory function has been partially outsourced to the drug. Without it, the world presses harder, the inner weather is louder, the anxiety is more insistent, and the sensory world may feel simultaneously flatter and more invasive. The person is not returning to their original baseline. They are experiencing a baseline that chronic cannabis use has altered.
This is why cannabis withdrawal, while not medically dangerous, is real and consistently underestimated. Irritability, anxiety, insomnia, restlessness, appetite disruption, and a pervasive flatness or unease in the weeks after stopping are common — particularly in people who have used heavily over years. The sensory and emotional richness that cannabis provided is gone. The natural system that should provide some version of regulation is still compromised. The membrane is gone and nothing has yet developed to replace it.
This is also where the question of dissociation becomes important. Dissociation is not merely distraction and not simply relaxation. It is an alteration in the ordinary integrity of contact between the self and experience — between the person and their own thoughts, feelings, body, other people, and the texture of shared reality. Cannabis moves in that direction because its basic action is already a modification of contact. In mild and early form, that modification may feel enriching — a more vivid, more spacious, more interesting experience of being. But the same mechanism that initially enriches contact can, at sufficient depth or duration, begin to erode it. The person may begin to feel unreal, or to feel that others are unreal. Time may seem altered or discontinuous. The sense of being a unified self, moving through a shared world, may loosen. These are not simply the unpleasant side effects of a drug. They are the far end of the same continuum that begins with the relief of modified contact. The drug that made experience feel more vivid and protected has, at sufficient depth, made it less legible. What began as a more hospitable world has become, in its extreme form, an estrangement from the only world there is.
That continuum matters clinically because it tells us something precise about what kind of person is most likely to find cannabis compelling and most likely to be harmed by it. The person whose membrane is too thin — who is precisely the person for whom cannabis initially works so well — is also the person for whom chronic use is most likely to deepen the dissociative direction. They are using a drug that modifies contact to manage a system that was already struggling to regulate contact. The relief is real. So is the risk. And the two are inseparable, because the same feature of the person that makes the drug so effective makes its long-term use so corrosive.
Treatment has to understand this full picture if it is to be useful. It is not enough to say that cannabis use is avoidant. That is true as far as it goes, but it misses what makes this particular avoidance so compelling and so durable. The person has found, in the cannabis state, a world with specific qualities that the unmediated world was not providing: sensory richness, mental freedom, protective enclosure, reduced self-criticism. Those are genuine experiences of genuine value, not mere rationalizations. The task of treatment is not to dismiss them but to understand them — to ask what specifically this person found there, what the unmediated world was failing to provide, and what would have to become possible for the cannabis world to become less necessary. Those questions often have a history, in the environments where the person’s sensitivity was first met or failed to be met, and in whether anyone ever helped them develop the capacity to modulate what was coming in.
Psychotherapy matters here because that capacity can, to a meaningful degree, be developed. Not quickly, and not by instruction. But within a relationship that is itself an experience of regulated contact — where things can be felt and said and examined without becoming overwhelming, where the intensity of experience can be modulated through the presence of another person who is neither too intrusive nor too absent — the person may gradually develop more ability to remain present to themselves and to others without requiring chemical assistance to make that presence bearable.
That is the deeper aim of treatment for cannabis dependence. Not simply stopping the drug, and not simply managing the difficult weeks when ordinary sensitivity returns without the membrane. The aim is the gradual development of what the cannabis has been supplying: a way of remaining in contact with experience — inner and outer both — at an intensity that does not overwhelm, and without needing a separate, protected world to make ordinary life livable. If that becomes possible, even partially, then the drug becomes less necessary because the problem it was solving has itself become more soluble.